Blog

T cells

How simpler implementations enable complex cell and gene therapies

After spending 12 years working in the biopharmaceutical industry – three of those here at Vineti – I’ve learned first-hand that cell and gene therapies (CGTs) present a unique environment for software implementation.st

Read More
May 27, 2021

Ori Biotech and Vineti Form Strategic Partnership to Deliver Integrated Manufacturing and Supply Chain Solutions for Cell and Gene Therapies

Platform integration will provide therapy developers with full end-to-end visibility, control, and insights into manufacturing and supply chain LONDON and...

May 12, 2021

Vineti Introduces PTM Essentials™ to Accelerate Cell and Gene Therapy Clinical Trials with a New Digital Supply Chain Solution

New PTM Essentials™ solution draws on Vineti’s industry-leading Personalized Therapy Management® (PTM) software platform to deliver breakthrough speed and simplicity for advanced...

April 22, 2021

Advanced Therapies Guide – seven key challenges and proven solutions – in advanced therapy clinical trials

Advanced therapies emerge from advanced science — and must overcome the operational complexity inherent in their patient-centric paradigm when they...

March 26, 2021

A new Five-minute Guide — seven key challenges in advanced therapy clinical trials

Advanced therapies emerge from advanced science — and must overcome the operational complexity inherent in their patient-centric paradigm when they...

March 24, 2021

Repost: a modern patient ID for personalized medicine

Today, Vineti released an announcement about new industry collaboration around our proposal for a new patient ID for cell and gene therapies....

January 11, 2021

Introducing new Vineti PTM® flexibility features: next-gen label printing and rescheduling innovations deliver critical workflow options that advanced therapies require

Introducing new Vineti PTM® flexibility features: next-gen label printing and rescheduling innovations deliver critical workflow options that advanced therapies require...

January 4, 2021

The Vineti Alliance Network — a preview of what’s next

For Vineti, 2020 has been all about continuing to deliver progress for advanced therapies, even amid an unpredictable year. One...

December 15, 2020

How PTM® Label Printing keeps every patient journey on track

In advanced therapies, little labels — the in-process labels on bags of cells and final drug products — can sometimes...

November 30, 2020

A true platform is the engine for advanced therapies

A Vineti technology perspective from Chief Technology Officer Phil Calvin Phil Calvin, Vineti’s Chief Technology Officer, is a long-time leader...

November 23, 2020

How digital solutions solve the “3D chess game” and drive Commercial success

A Vineti technology perspective from Chief Commercial Officer Joe DePinto Joe DePinto, Vineti’s Chief Commercial Officer, is a long-time leader...

November 17, 2020

A modern patient ID for personalized medicine

Patient-specific therapeutics must be delivered to the patient they are intended to treat. That concept is easy to say —...

November 17, 2020

Now is the time for proven technology that drives scale

A Vineti technology perspective from CEO and Co-founder Amy DuRoss   The underlying medical science behind cell and gene therapies continues...